Experts assure that covid-19 is here to stay, and it does not take an expert to see that this virus can affect anyone, and that the disease, as can be seen in the studies published by the World Health Organization Health, it can cause symptoms ranging from mild to very severe.
A fourth COVID-19 booster shot is estimated to be available to most Americans in early September, based on current projections from federal health officials. Covid-19 vaccines modified to better repel omicron variants are expected to be approved by the Food and Drug Administration (FDA) and be available in the coming weeks.
This booster vaccine has been specifically designed to deal with the Ómicron BA.4 and BA.5 sub-variants, as well as to create more immunity in the original strains of SARS-CoV-2 (that is why it is called “bivalent”).
The updated booster vaccines, made by the Pfizer-BioNTech and Moderna teams, aim to reduce the risk of further spread of the Omicron-CoV-2 subvariant this fall. More people will be able to get this vaccine than previous boosters: eligibility will be broader, encompassing more than just the elderly and immunocompromised.
Pfizer’s booster could be available immediately after federal approval for those 12 and older, while Moderna’s vaccine could be available at a later date, and initial filings suggest its boosters will still be targeted at those 18 and older. .
The administration of President Joe Biden hopes that the updated reinforcements can help counter the winter increase in the spread of Covid-19 in a population tired of the virus and vaccines.